Skip to main content

Lidocaine / tetracaine topical Pregnancy and Breastfeeding Warnings

Medically reviewed by Last updated on Mar 31, 2021.

Lidocaine / tetracaine topical is also known as: Pliaglis, S-Caine Peel, Synera

Lidocaine / tetracaine topical Pregnancy Warnings

Lidocaine-tetracaine topical has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal evidence of fetotoxicity following administration of up to 6.6 times the human dose. There are no controlled data in human pregnancy. Lidocaine-tetracaine topical is only recommended for use during pregnancy when benefit outweighs risk.

See references

Lidocaine / tetracaine topical Breastfeeding Warnings

Lidocaine is excreted into human milk. There are no data on the excretion of tetracaine into human milk. The effects in the nursing infant are unknown. The manufacturer recommends that caution be used when administering lidocaine-tetracaine topical to nursing women.

See references

References for pregnancy information

  1. "Product Information. Synera (lidocaine-tetracaine topical)." Ferndale Laboratories Inc (2005):

References for breastfeeding information

  1. "Product Information. Synera (lidocaine-tetracaine topical)." Ferndale Laboratories Inc (2005):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.